SB

Sachin Bagwan

Active Director Director DIN 09754866
DIN 09754866 First appointment Oct 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Sachin Bagwan

Data last updated:

Sachin Bagwan is a Director at Jbprides Pharma Private Limited (since 2022). The company operates in Chemicals. Jbprides Pharma Private Limited reported revenue of ₹16.2 Lakh (FY 2025).

DIN 09754866
Primary Designation Director
Industry Chemicals
First Appointment 03 Oct 2022
Oldest Company Age 4 yrs
Largest company Jbprides Pharma Private Limited · ₹16.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jbprides Pharma Private Limited U24110MP2022PTC062944
Director03 Oct 20222022₹16.2 Lakh (FY 2025)Active

Board colleagues of Sachin Bagwan

NameDINCompanyDesignation
Bablu Bagwan09754865Jbprides Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jbprides Pharma Private Limited
Premium access

Shareholding and investment profile for Sachin Bagwan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachin Bagwan

Sachin Bagwan currently holds 1 directorship: Jbprides Pharma Private Limited (Director, since 03 Oct 2022, revenue ₹16.2 Lakh (FY 2025)).

Sachin Bagwan was first appointed on 03 Oct 2022 as Director at Jbprides Pharma Private Limited.

The current boards of Sachin Bagwan's companies include Bablu Bagwan (Jbprides Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available